scholarly article | Q13442814 |
P50 | author | Steven Rosenberg | Q2347448 |
P2093 | author name string | Lam JS | |
Hwu P | |||
Royal RE | |||
Reeves ME | |||
P433 | issue | 24 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | dendritic cell | Q506253 |
P304 | page(s) | 5672-5677 | |
P577 | publication date | 1996-12-01 | |
P1433 | published in | Cancer Research | Q326097 |
P1476 | title | Retroviral transduction of human dendritic cells with a tumor-associated antigen gene | |
P478 | volume | 56 |
Q37189574 | An effective vaccine against colon cancer in mice: use of recombinant adenovirus interleukin-12 transduced dendritic cells |
Q42925679 | Antitumor Vaccines Based on Dendritic Cells: From Experiments using Animal Tumor Models to Clinical Trials |
Q40834747 | Can immunotherapy by gene transfer tip the balance against colorectal cancer? |
Q36380749 | Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity |
Q36380718 | Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases |
Q39612180 | Development of minimal lentivirus vectors derived from simian immunodeficiency virus (SIVmac251) and their use for gene transfer into human dendritic cells |
Q55473331 | Effects of glioma cells on maturation of dendritic cells. |
Q35039002 | Gene-modified dendritic cells for immunotherapy against cancer |
Q41687574 | Human tumor antigens recognized by T-cells |
Q36908547 | Hybrids of dendritic cells and tumor cells generated by electrofusion simultaneously present immunodominant epitopes from multiple human tumor-associated antigens in the context of MHC class I and class II molecules |
Q28347565 | In vitro generation of human CD86+ dendritic cells from CD34+ haematopoietic progenitors by PMA and in serum-free medium |
Q34792069 | Induction of CD4(+) T cell-dependent antitumor immunity by TAT-mediated tumor antigen delivery into dendritic cells |
Q51240658 | Isolation and transduction of monocytes: promising vehicles for therapeutic arteriogenesis. |
Q47287396 | Lentiviral gp34/OX40L gene transfer into dendritic cells facilitates alloreactive CD4+ T-cell response in vitro |
Q46899687 | MART-1 adenovirus-transduced dendritic cell immunization in a murine model of metastatic central nervous system tumor |
Q35159565 | Macrophage inflammatory protein 3alpha transgene attracts dendritic cells to established murine tumors and suppresses tumor growth |
Q41788640 | Mapping the HLA-A24-restricted T-cell epitope peptide from a tumour-associated antigen HER2 / neu: possible immunotherapy for colorectal carcinomas |
Q38744180 | Optimized protocol for efficient transfection of dendritic cells without cell maturation |
Q38832705 | Optimizing the process of nucleofection for professional antigen presenting cells |
Q34030512 | Potential applications of gene therapy in the patient with cancer |
Q36327106 | Presentation of tumor antigens by dendritic cells genetically modified with viral and nonviral vectors |
Q37055696 | TLR-independent type I interferon induction in response to an extracellular bacterial pathogen via intracellular recognition of its DNA. |
Q64381308 | Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells |
Q36438078 | Tumor antigens discovery: perspectives for cancer therapy |
Q38468370 | Validation of efficient high-throughput plasmid and siRNA transfection of human monocyte-derived dendritic cells without cell maturation |
Search more.